ScanCell’s DNA Plasmid-Cancer Vaccine Shows Promise In Melanoma
This article was originally published in The Pink Sheet Daily
Executive Summary
ScanCell Holdings’ potential DNA cancer vaccine, which is administered via an electrical field-driven device, shows preliminary evidence of efficacy in late-stage melanoma patients.